glp-1 and parkinson's Are we measuring the wrong primary outcome for drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1R Agonists - Glucagon-Like Peptide

Highlights Chronic, but not acute, iron or GSH imbalance induces chronoferroptosis in neuronal cells

Mature erythrocytes have limited synthetic and repair capacities, but to effectively function they must have biochemical pathways that generate enough energy to support cellular function and allow haemoglobin to be maintained in a state that can effectively bind oxygen

Thats because our bodys repair abilities arent what they used to be

GLP-1 medications send signals to the brain and gut receptors and balance cravings and improve the feeling of satiety

Since the discovery of ferroptosis, an increasing number of drugs have been shown to exert their efficacy by regulating ferroptosis

11 One of the most powerful features of ro.OS is its Smart Task Routing